Session Details

Chair:

• Ricardo Baptista, PhD, SmartCella, Sweden

Speakers:

• Marcia Mata, PhD, Cell and Gene Therapy Catapult, United Kingdom - Towards industrialisation of iPSC-derived allogeneic cell therapy
• Sven Verguts, PhD, Merck Group, Belgium - Viral Gene Therapy: Start right to Scale right
• Rob Allen, PhD, DHC Europe Ltd Dark Horse Consulting, United Kingdom - The 4Cs of Process Planning: Building your Manufacturing Process with Commercialization in Mind from Day One

This session will address the core considerations in developing and continuous improvement of your manufacturing process during the product life cycle.

Session Objectives

1. An understanding of the key considerations in designing and improving your manufacturing process
2. An appreciation of Phase based development including regulatory requirements and scalability considerations for the end goal of commercialisation